Información:
Error:
ID
44054
Descripción
Study part: Status of treatment blind. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Palabras clave
Versiones (2)
- 19/6/18 19/6/18 -
- 20/9/21 20/9/21 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
20 de septiembre de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Status of treatment blind Pazopanib Macular Degeneration MD1103367
Status of treatment blind
- StudyEvent: ODM
Similar models
Status of treatment blind
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
STATUS OF TREATMENT BLIND (Blind)
C0749659 (UMLS CUI-1)
C2347038 (UMLS CUI-2)
C2347038 (UMLS CUI-2)
Item
Was the treatment blind broken during the study?
text
C0749659 (UMLS CUI [1])
C2347038 (UMLS CUI [2])
C2347038 (UMLS CUI [2])
CL Item
No (N)
CL Item
Yes (Y)
Date and time Blinded Clinical Study study end
Item
Date/time blind broken
datetime
C1264639 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C2983670 (UMLS CUI [1,3])
C2347038 (UMLS CUI [1,2])
C2983670 (UMLS CUI [1,3])
CL Item
Medical emergency requiring identification of investigational product for further treatment (Medical emergency requiring identification of investigational product for further treatment)
CL Item
Other (Other)
Other
Item
Other, specify
text
C0205394 (UMLS CUI [1])